RecruitingNCT07058935
The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry (AP ViV Registry)
Sponsor
National Heart Centre Singapore
Enrollment
150 participants
Start Date
Mar 17, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
A retrospective and prospective, observational, multicenter cohort study of consecutive patients undergoing transcatheter mitral/tricuspid ViV or ViR procedure with balloon expandable valve across participating sites in Asia-Pacific.
Eligibility
Min Age: 21 Years
Inclusion Criteria2
- Age ≥ 21
- Had at least one documented Mitral valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. (Retrospective) OR Planned to undergo a Mitral valve-in-valve/valve-in-ring procedure. (Prospective) OR Had at least one documented Tricuspid valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. (Retrospective) OR Planned to undergo a Tricuspid valve-in-valve/valve-in-ring procedure. (Prospective)
Exclusion Criteria2
- Active endocarditis
- Any other conditions which investigator deems unsuitable for participation.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07058935
Related Trials
Mosaic Mitral Valve: Long-Term Outcomes in Patients Under 65
NCT069175861 location
Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
NCT072249061 location
Medtronic Cardiac Surgery PMCF Registry
NCT0407342026 locations
Valvular Heart Disease in Women Registry
NCT071969302 locations
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
NCT059720701 location